Assessing viral gene therapy in neuroendocrine models

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Neuronal gene expression manipulation is crucial for understanding and treating CNS diseases.
• Traditional transfection methods were limited to dividing cells, necessitating transgenic animals for neuronal gene manipulation.
• Viral gene transfer systems, particularly recombinant adenovirus (Ad) vectors, have emerged as powerful tools for CNS gene therapy.

Purpose of the Study:

• To evaluate the efficacy of recombinant adenovirus (Ad) vectors for gene transfer in postmitotic neurons of the CNS.
• To investigate the potential of Ad-mediated gene therapy for treating hypothalamic diabetes insipidus using the Brattleboro rat model.

Main Methods:

• Utilized recombinant adenovirus (Ad) vectors encoding arginine vasopressin (AVP) cDNA.
• Injected the Ad vector into the supraoptic nuclei of the hypothalamus in Brattleboro rats.
• Monitored daily water intake, micturition volume, and urine osmolality to assess therapeutic efficacy.

Main Results:

• Successful transfection of postmitotic neurons in the CNS was achieved.
• Long-term reversal of diabetes insipidus phenotype was observed in treated Brattleboro rats.
• Reduced daily water intake and micturition, with increased urine osmolality, persisted for up to 4 months.

Conclusions:

• Adenovirus-mediated delivery of arginine vasopressin (AVP) cDNA is an effective strategy for long-term gene therapy in the CNS.
• The Brattleboro rat model of hypothalamic diabetes insipidus is a valuable tool for noninvasively examining CNS gene therapy efficacy.